Irinotecan Hydrochloride 16714-0131-01
- Manufacturer
- Northstar Rx Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 15, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA212993
Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Irinotecan Hydrochloride | 20 mg/mL |
Drug Class
Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]
Selected Package
16714-0131-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (16714-131-01) / 5 mL in 1 VIAL, SINGLE-DOSE